而推动这一转变的，是胚胎评分技术的革新——通过整合多基因风险评分、高通量测序与人工智能分析，科学家如今能在植入前更准确地评估胚胎的健康潜力。正是这些进展，使其入选《麻省理工科技评论》2026 年“十大突破性技术”。

Every year, 20,000 genetic tests are sent to laboratories in the UK, US, Germany, Spain and Finland - senators want to bring that testing back to Ireland ...

Rare diseases (RD) are more common than you might think. For every 20 people you know, one is likely affected by a rare disease. Of the 7,000 known RD conditions, 80% have a genetic origin, yet over ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM) company and a leader in clinical genomic testing, announced today that a ...

Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.